bioMérieux ConnectionAn educational resource brought to you by bioMérieux, Inc.
An educational resource brought to you by bioMérieux, Inc.
In the past, the development of antimicrobial stewardship efforts mainly focused on prescribers and pharmacists. Today, as the threat of AMR increases, there is growing recognition of the need for efforts to also focus on other stakeholders in antibiotic use—particularly nurses
Given the dependence of modern medicine on antimicrobial drugs, and the inevitability of evolution, why is bringing a new antibiotic to market so difficult, and why are so many companies leaving the industry or going bankrupt?
Our 2019 toolkit provides resources for the public to learn about antimicrobial resistance, as well as resources for healthcare, scientific, and administrative professionals.
AMR has been identified as a major threat by the World Health Organization due to the lack of new antibiotics in the development pipeline and infections caused by multi-drug resistant pathogens becoming untreatable.
Amid the spread of COVID-19, testing for SARS-COV-2, the virus...
Patients at the greatest risk for secondary infections, particularly infections...